Gastroenterology and Artificial Intelligence: 4th Annual Global Artificial Intelligence Summit (On-Demand | August 2022-Ethical Considerations Recorded Presentation

Video Transcription

Video Summary

In this video, ophthalmologist Michael Abramoff discusses the use of autonomous artificial intelligence (AI) in healthcare and its potential to address health disparities. He explains the difference between autonomous and assistive AI, where autonomous AI makes medical decisions entirely without human oversight and assistive AI aids clinicians in decision-making. Abramoff focuses on the application of autonomous AI in the diagnosis of diabetic retinopathy and macular degeneration.<br /><br />He highlights the challenges of implementing healthcare AI, including the scarcity of high-quality data, particularly for normal cases, and the rarity of certain diseases. He also emphasizes the importance of ethics and the need for a balanced approach that considers patient benefit, autonomy, justice, and responsibility. Abramoff discusses the necessary considerations when designing and evaluating AI systems, including the use of patient data, liability, and potential biases.<br /><br />He notes the importance of stakeholder acceptance and support, highlighting collaborations with regulatory bodies like the FDA, patient organizations, Congress, payers, and healthcare providers. Abramoff also discusses the need for transparency, openness, and publication to address concerns and build trust. He provides examples of regulatory and reimbursement frameworks that have been developed for AI in healthcare.<br /><br />Finally, Abramoff stresses the importance of keeping the focus on improving patient outcomes and addressing health disparities, and urges caution to avoid backlash and ethical issues that can derail progress. He concludes with the importance of a comprehensive approach that integrates regulatory, ethical, and reimbursement considerations to ensure the responsible and effective use of AI in healthcare.

Asset Subtitle

Michael Abramoff, MD
Olivia Niederhauser, MD

Keywords

autonomous artificial intelligence

healthcare

diabetic retinopathy

macular degeneration

ethics

patient outcomes